Clinical Trials Directory

Trials / Completed

CompletedNCT02664376

Prevalence of Sarcopenia and Its Geriatric Features

Status
Completed
Phase
Study type
Observational
Enrollment
834 (actual)
Sponsor
Brugmann University Hospital · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to determine the prevalence of sarcopenia in a geriatric hospital ward. Sarcopenia is defined by a loss of muscle mass, loss of muscle strength and loss of muscle quality. It is a geriatric syndrome that, to this date, is not systematically tracked in clinical practice. In order to detect sarcopenia, the investigators will use the operational definition proposed by the European Working Group (EWGSOP) involving the measure of three parameters, namely the speed of walking, the muscle strength and the measurement of the muscular mass.

Conditions

Interventions

TypeNameDescription
OTHERSarcopenia detectionThe assessment of sarcopenia is performed according to the recommendations of the EWGSOP (European Working Group on Sarcopenia in Older people). Three measurements are made: * Muscle mass measurement by dual energy X-ray absorptiometry (DEXA). * Walking speed measurement * Hand grip test A diagnosis of sarcopenia is established if the walking speed is inferior to 0.8 m/sec, the muscular strength is low and the muscular mass is low. Data regarding the geriatric characteristics of this sarcopenic population will be collected.

Timeline

Start date
2016-01-01
Primary completion
2018-01-18
Completion
2018-01-18
First posted
2016-01-27
Last updated
2018-01-26

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02664376. Inclusion in this directory is not an endorsement.